Can Cannabis as Anti-Inflammatory Help with Trigeminal Neuralgia?

PostedFebruary 22, 2026

UpdatedFebruary 22, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Trigeminal neuralgia often involves intense neuropathic pain that can be worsened by inflammation. Using cannabis as anti-inflammatory may help manage these symptoms. Both CBD and THC play roles in reducing inflammation and providing targeted pain relief. Understanding how these cannabinoids work can guide patients toward more effective inflammation management strategies.

How Cannabis as Anti-Inflammatory Works

Incorporating cannabis as anti-inflammatory in treatment plans may help reduce nerve irritation and associated discomfort.

CBD for Inflammation Control

CBD is widely recognised for its anti-inflammatory properties. It may alleviate nerve pain without producing psychoactive effects, making it suitable for long-term neuropathic pain relief.

THC and Pain Reduction

THC also contributes to inflammation management while providing potent analgesic effects. It may be particularly useful during severe pain episodes but requires careful dosing due to its psychoactive nature.

Synergistic Effects of CBD and THC

Combining CBD and THC can enhance overall pain relief through the entourage effect, optimising both anti-inflammatory and analgesic benefits.

Choosing the Right Approach

Patients should consult healthcare providers to tailor cannabis as anti-inflammatory treatments for their unique symptoms. Proper selection of cannabinoids, dosage, and delivery methods ensures safer and more effective inflammation management.

Using cannabis as anti-inflammatory may provide a natural and targeted option for reducing trigeminal nerve irritation while supporting overall neuropathic pain relief.

If you’re exploring cannabis treatment options for trigeminal neuralgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and trigeminal neuralgia.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.